Table 1.

Demographics and clinical characteristics

Baseline Characteristics	N = 61
Female, n (%)	28 (45%)
Age, Mean (SD)	14.6 (2.7)
Race/ethnicity, n (%)
White, non-Hispanic	31 (51%)
White, Hispanic	20 (33%)
African American	5 (8%)
Other	5 (8%)
Disease duration, years, median (IQR)	0.5 (0.2 – 1.2)
DMT exposed, n (%)	45 (74%)
25(OH) Vitamin D in ng/mL, Mean (SD)	23.3 (8.8)
EDSS, Median (IQR)	1.5 (1.0 – 2.0)
Follow-up duration in years, Median (IQR)	2.8 (1.7 – 4.9)
Number of relapses during follow-up, Median (IQR)	1 (0 – 2)